Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques
- PMID: 24947525
- DOI: 10.1161/ATVBAHA.114.303209
Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques
Abstract
Objective: Coagulation factor XI is proposed as therapeutic target for anticoagulation. However, it is still unclear whether the antithrombotic properties of factor XI inhibitors influence atherosclerotic disease and atherothrombosis. Our aim is to investigate whether factor XI antisense oligonucleotides could prevent thrombus formation on acutely ruptured atherosclerotic plaques.
Approach and results: Atherosclerotic plaques in the carotid arteries of Apoe(-/-) mice were acutely ruptured using ultrasound. The subsequent thrombus formation was visualized and quantified by intravital microscopy and immunohistochemistry. Mice were pretreated with either factor XI antisense or nonsense oligonucleotides (50 mg/kg) to lower factor XI plasma levels. A tail bleeding assay was used to determine the safety. On plaque rupture, initial platelet adhesion and platelet plug formation were not impaired in animals treated with factor XI antisense oligonucleotides. However, the ensuing thrombus formation and fibrin deposition were significantly lower after 5 to 10 minutes (P<0.05) in factor XI antisense oligonucleotide-treated animals without inducing a bleeding tendency. Furthermore, thrombi from antisense-treated animals were less stable than thrombi from placebo-treated animals. Moreover, macrophage infiltration and collagen deposition were lower in the carotid arteries of factor XI antisense-treated animals. No neutrophils were present.
Conclusions: Factor XI antisense oligonucleotides safely prevent thrombus formation on acutely ruptured atherosclerotic plaques in mice. Furthermore, perturbed carotid arteries from factor XI antisense-treated animals show a less severe inflammatory response.
Keywords: atherosclerosis; blood coagulation; factor XI; thrombosis.
© 2014 American Heart Association, Inc.
Comment in
-
New targets for atherothrombosis.Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1607-8. doi: 10.1161/ATVBAHA.114.304005. Arterioscler Thromb Vasc Biol. 2014. PMID: 25031326 Free PMC article. No abstract available.
Similar articles
-
Factor XII regulates the pathological process of thrombus formation on ruptured plaques.Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1674-80. doi: 10.1161/ATVBAHA.114.303315. Epub 2014 May 22. Arterioscler Thromb Vasc Biol. 2014. PMID: 24855058
-
Effect of chronic treatment with acetylsalicylic acid and clopidogrel on atheroprogression and atherothrombosis in ApoE-deficient mice in vivo.Thromb Haemost. 2008 Jan;99(1):190-5. doi: 10.1160/TH07-03-0235. Thromb Haemost. 2008. PMID: 18217153
-
Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice.Circ Res. 2015 Feb 13;116(4):587-99. doi: 10.1161/CIRCRESAHA.116.304035. Epub 2014 Dec 3. Circ Res. 2015. PMID: 25472975
-
Acute and persistent platelet and coagulant activities in atherothrombosis.J Thromb Haemost. 2015 Jun;13 Suppl 1:S272-80. doi: 10.1111/jth.12972. J Thromb Haemost. 2015. PMID: 26149036 Review.
-
Intrinsic pathway of coagulation and arterial thrombosis.Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2507-13. doi: 10.1161/ATVBAHA.107.155952. Epub 2007 Oct 4. Arterioscler Thromb Vasc Biol. 2007. PMID: 17916770 Review.
Cited by
-
Platelets: Context-Dependent Vascular Protectors or Mediators of Disease.Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):e25-9. doi: 10.1161/ATVBAHA.115.305898. Arterioscler Thromb Vasc Biol. 2015. PMID: 26109740 Free PMC article. Review. No abstract available.
-
Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications.J Thromb Thrombolysis. 2018 May;45(4):593-602. doi: 10.1007/s11239-018-1641-2. J Thromb Thrombolysis. 2018. PMID: 29550950 Free PMC article. Review.
-
Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.J Thromb Haemost. 2021 Apr;19(4):1001-1017. doi: 10.1111/jth.15236. Epub 2021 Feb 10. J Thromb Haemost. 2021. PMID: 33421301 Free PMC article.
-
Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study.World J Clin Cases. 2022 Mar 26;10(9):2700-2709. doi: 10.12998/wjcc.v10.i9.2700. World J Clin Cases. 2022. PMID: 35434115 Free PMC article.
-
Recent advances in the discovery and development of factor XI/XIa inhibitors.Med Res Rev. 2018 Sep;38(6):1974-2023. doi: 10.1002/med.21503. Epub 2018 May 4. Med Res Rev. 2018. PMID: 29727017 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous